| Original language | English |
|---|---|
| Pages (from-to) | 965-967 |
| Number of pages | 3 |
| Journal | Journal of Rheumatology |
| Volume | 44 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2017 |
Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice
Martijn Kuijper*, Leander Buisman, Mieke Hazes, Angelique Weel
*Corresponding author for this work
Research output: Contribution to journal › Editorial › Academic › peer-review
1
Citation
(Scopus)